AI
VCYT icon

Atria Investments’s Veracyte VCYT Stock Holding History

Atria Investments’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$243K Buy
7,540
+1,081
+17% +$40K ﹤0.01% 1879
2025
Q4 		$272K Sell
6,459
-205
-3% -$8.26K ﹤0.01% 1792
2025
Q3 		$229K Buy
+6,664
New +$191K ﹤0.01% 1873

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Atria Investments's VCYT Position: Q1 2026 in Review

Atria Investments increased its Veracyte (VCYT) stake by 17% in Q1 2026, buying an estimated $40K and bringing the position to 7,540 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

Atria Investments first reported a position in VCYT in Q3 2025 and has held it in 3 quarters since. The position peaked at $272K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Atria Investments held 7,540 shares of Veracyte worth $243K as of Q1 2026.
  • Atria Investments bought 1,081 Veracyte shares in Q1 2026, an estimated $40K.
  • Veracyte made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1879 holding.
  • Atria Investments first reported a position in Veracyte in Q3 2025 and has held it in 3 quarters since.
  • Atria Investments's Veracyte position peaked at $272K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.